论文部分内容阅读
目的 评价肝段性栓塞化疗在肝癌介入治疗中的的疗效、不良反应和应用价值。方法 超选择肝段性栓塞化疗和非超选择常规插管栓塞化疗各 2 0例 ,前者以超选择技术进入肿瘤血管进行栓塞化疗 ,后者以插管进入肝固有动脉或肝左右动脉进行栓塞化疗。以碘油填充效果、介入术后第 7天肝功能恢复情况、生活质量评分及平均住院花费为观察终点指标。结果 两组碘油填充效果、生存质量评分具有统计学显著性差异 ;两组介入术后第 7天肝功能恢复情况无统计学差异 ;治疗组花费较对照组高 ,但患者能耐受。结论 肝段性栓塞化疗在肝癌介入治疗中有明显的应用价值
Objective To evaluate the efficacy, adverse reactions and application value of hepatic segmental embolization chemotherapy in interventional treatment of liver cancer. Methods Twenty patients undergoing transcatheter arterial chemoembolization (TACE) and non-superselective conventional intubation and chemotherapy (TACE) were enrolled in this study. The former was treated by transcatheter arterial chemoembolization with superselective technology. The latter was intubated into the hepatic artery or the left and right hepatic artery for embolization . Lipiodol-filling effect, liver function recovery after 7 days, quality of life score and average hospitalization cost were observed end points. Results There were statistically significant differences in filling effect and quality of life between the two groups. There was no significant difference in liver function recovery between the two groups on the seventh day after operation. The treatment group was more expensive than the control group but tolerated. Conclusion The hepatic segmental embolization chemotherapy has obvious value in the interventional therapy of liver cancer